Release Agreements in the Health Care Equipment & Supplies Industry
126 Contracts & Agreements
- ABIOMED Inc (1 contract)
- ACCURAY INC (1)
- AdvanSource Biomaterials Corp (1)
- ANTARES PHARMA, INC. (1)
- ARGOS THERAPEUTICS INC (3)
- Baxter International Inc. (2)
- BIOMIMETIC THERAPEUTICS, INC. (1)
- BioSig Technologies, Inc. (1)
- Boston Scientific (2)
- BRAIN SCIENTIFIC INC. (1)
- Cascadian Therapeutics, Inc. (1)
- CESCA THERAPEUTICS INC. (6)
- Colfax CORP (1)
- CryoLife, Inc. (1)
- EMULATE THERAPEUTICS, INC. (1)
- ERBA Diagnostics, Inc. (1)
- GenMark Diagnostics, Inc. (1)
- GUIDED THERAPEUTICS INC (2)
- Haemonetics (1)
- HYPERION THERAPEUTICS INC (1)
- IMARX THERAPEUTICS INC (1)
- InspireMD, Inc. (8)
- Integer Holdings Corporation (4)
- Integra Lifesciences Holdings (2)
- Invacare Corporation (1)
- INVIVO THERAPEUTICS HOLDINGS CORP. (1)
- INVO Bioscience, Inc. (1)
- iRhythm Technologies, Inc. (2)
- IRIDEX CORP (2)
- LivaNova (1)
- Merit Medical Systems, Inc. (1)
- MICRON SOLUTIONS INC (1)
- MILESTONE SCIENTIFIC INC. (1)
- MISONIX INC (1)
- NanoVibronix, Inc. (15)
- Natus Medical Incorporated (3)
- NEUROONE MEDICAL TECHNOLOGIES Corp (1)
- NOVELION THERAPEUTICS INC. (6)
- Ocata Therapeutics, Inc. (1)
- Orthofix Medical Inc. (2)
- OSIRIS THERAPEUTICS, INC. (2)
- OxySure Therapeutics, Inc. (2)
- PERNIX THERAPEUTICS HOLDINGS, INC. (3)
- Precision Therapeutics Inc. (4)
- ReWalk Robotics Ltd. (1)
- RTI SURGICAL, INC. (2)
- Sensus Healthcare, Inc. (1)
- STRATA Skin Sciences, Inc. (1)
- Stryker Corp. (1)
- Talon Therapeutics, Inc. (2)
- TearLab Corp (6)
- Tobira Therapeutics, Inc. (1)
- TRANSENTERIX INC. (3)
- TREACE MEDICAL CONCEPTS, INC. (1)
- Valeritas Holdings Inc. (1)
- ViewRay, Inc. (4)
- WOUND MANAGEMENT TECHNOLOGIES, INC. (1)
- Xtant Medical Holdings, Inc. (2)
- Zimmer Biomet Holdings (2)
- Zosano Pharma Corp (1)
- Option Cancellation and Release Agreement, dated November 29, 2023, by and between NanoVibronix, Inc. and Thomas Mika (NanoVibronix, Inc., Filed With SEC on December 4, 2023)
- Option Cancellation and Release Agreement, dated November 29, 2023, by and between NanoVibronix, Inc. and Stephen Brown (NanoVibronix, Inc., Filed With SEC on December 4, 2023)
- Option Cancellation and Release Agreement, dated November 29, 2023, by and between NanoVibronix, Inc. and Michael Ferguson (NanoVibronix, Inc., Filed With SEC on December 4, 2023)
- Option Cancellation and Release Agreement, dated November 29, 2023, by and between NanoVibronix, Inc. and Martin Goldstein (NanoVibronix, Inc., Filed With SEC on December 4, 2023)
- Option Cancellation and Release Agreement, dated November 29, 2023, by and between NanoVibronix, Inc. and Maria Schroeder (NanoVibronix, Inc., Filed With SEC on December 4, 2023)
- Option Cancellation and Release Agreement, dated November 29, 2023, by and between NanoVibronix, Inc. and Harold Jacob (NanoVibronix, Inc., Filed With SEC on December 4, 2023)
- Option Cancellation and Release Agreement, dated November 29, 2023, by and between NanoVibronix, Inc. and Christopher Fashek (NanoVibronix, Inc., Filed With SEC on December 4, 2023)
- Option Cancellation and Release Agreement, dated November 29, 2023, by and between NanoVibronix, Inc. and Brian Murphy (NanoVibronix, Inc., Filed With SEC on December 4, 2023)
- Option Cancellation and Release Agreement, dated November 29, 2023, by and between NanoVibronix, Inc. and Aurora Cassirer (NanoVibronix, Inc., Filed With SEC on December 4, 2023)
- Press Release, dated as of August 8, 2023 (Sensus Healthcare, Inc., Filed With SEC on August 11, 2023)
- Mutual General Release Agreement between the Company and John Butters and Lisa Butters (EMULATE THERAPEUTICS, INC., Filed With SEC on July 10, 2023)
- Press Release issued by Boston Scientific Corporation, dated June 27, 2023 (Boston Scientific, Filed With SEC on June 27, 2023)
- General Release of Claims, dated May 10, 2023, by and between ViewRay, Inc. and William P. Burke (ViewRay, Inc., Filed With SEC on May 11, 2023)
- Resignation and Release of Claims by and between iRhythm Technologies, Inc. and David A. Vort, dated July 18, 2022 (iRhythm Technologies, Inc., Filed With SEC on July 19, 2022)
- Resignation and Release Agreement, dated March 13, 2022, between iRhythm Technologies, Inc. and Kevin M. King (iRhythm Technologies, Inc., Filed With SEC on March 14, 2022)
- Resignation Agreement and Release effective as of January 3, 2022 between Xtant Medical Holdings, Inc. and Greg Jensen (Xtant Medical Holdings, Inc., Filed With SEC on March 8, 2022)
- Release Agreement by and between Treace Medical Concepts, Inc. and Dipak A. Rajhansa (TREACE MEDICAL CONCEPTS, INC., Filed With SEC on November 4, 2021)
- Agreement and Release by and between the Company and Carl Schwartz dated March 19, 2021 (Precision Therapeutics Inc., Filed With SEC on March 23, 2021)
- Press Release dated March 15, 2021 (INVO Bioscience, Inc., Filed With SEC on March 15, 2021)
- Option Cancellation and Release Agreement, dated November 2, 2020, by and between NanoVibronix, Inc. and Thomas Mika (NanoVibronix, Inc., Filed With SEC on November 5, 2020)
- Option Cancellation and Release Agreement, dated November 2, 2020, by and between NanoVibronix, Inc. and Stephen Brown (NanoVibronix, Inc., Filed With SEC on November 5, 2020)
- Option Cancellation and Release Agreement, dated November 2, 2020, by and between NanoVibronix, Inc. and Michael Ferguson (NanoVibronix, Inc., Filed With SEC on November 5, 2020)
- Option Cancellation and Release Agreement, dated November 2, 2020, by and between NanoVibronix, Inc. and Martin Goldstein (NanoVibronix, Inc., Filed With SEC on November 5, 2020)
- Option Cancellation and Release Agreement, dated November 2, 2020, by and between NanoVibronix, Inc. and Christopher Fashek (NanoVibronix, Inc., Filed With SEC on November 5, 2020)
- Option Cancellation and Release Agreement, dated November 2, 2020, by and between NanoVibronix, Inc. and Brian Murphy (NanoVibronix, Inc., Filed With SEC on November 5, 2020)
- General Release of Claims dated September 14, 2020 by and between Brian Mitchell and GenMark Diagnostics, Inc (GenMark Diagnostics, Inc., Filed With SEC on October 28, 2020)
- Press Release (BRAIN SCIENTIFIC INC., Filed With SEC on June 17, 2020)
- Press release dated October 17, 2019 issued by TransEnterix, Inc (TRANSENTERIX INC., Filed With SEC on October 17, 2019)
- Press release dated April 8, 2019 (Valeritas Holdings Inc., Filed With SEC on April 8, 2019)
- LivaNova Press Release dated April 5, 2019 (LivaNova, Filed With SEC on April 5, 2019)
- Agreement and General Release by and between Richard D. Gorelick and Integra LifeSciences Corporation (Integra Lifesciences Holdings, Filed With SEC on February 26, 2019)
- Press Release, dated January 25, 2019 (MILESTONE SCIENTIFIC INC., Filed With SEC on January 25, 2019)
- Release of Claims Agreement, dated July 20, 2018, by and between the Registrant and Charles Nicolette (ARGOS THERAPEUTICS INC, Filed With SEC on November 19, 2018)
- Release of Claims Agreement, dated July 20, 2018, by and between the Registrant and Richard Katz (ARGOS THERAPEUTICS INC, Filed With SEC on November 19, 2018)
- Release of Claims Agreement, dated July 20, 2018, by and between the Registrant and Jeffrey D. Abbey (ARGOS THERAPEUTICS INC, Filed With SEC on November 19, 2018)
- Release Agreement and Acknowledgement, dated May 25, 2018, between Integer Holdings Corporation and Gary J. Haire (Integer Holdings Corporation, Filed With SEC on August 3, 2018)
- Release Agreement and Acknowledgement, dated August 22, 2017, between Integer Holdings Corporation and Kristin Trecker (Integer Holdings Corporation, Filed With SEC on October 30, 2017)
- SeparationAND Release Agreement (NEUROONE MEDICAL TECHNOLOGIES Corp, Filed With SEC on July 20, 2017)
- AGREEMENT AND GENERAL RELEASE (Haemonetics, Filed With SEC on May 24, 2017)
- RELEASE AGREEMENT AND ACKNOWLEDGEMENT (Integer Holdings Corporation, Filed With SEC on May 9, 2017)
